These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 16683083

  • 1. Imaging before and after multimodal treatment for malignant pleural mesothelioma.
    Fiore D, Baggio V, Sotti G, Muzzio PC.
    Radiol Med; 2006 Apr; 111(3):355-64. PubMed ID: 16683083
    [Abstract] [Full Text] [Related]

  • 2. [Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy].
    Sienel W, Kirschbaum A, Passlick B.
    Zentralbl Chir; 2008 Jun; 133(3):231-7. PubMed ID: 18563687
    [Abstract] [Full Text] [Related]

  • 3. What is the best way to diagnose and stage malignant pleural mesothelioma?
    Zahid I, Sharif S, Routledge T, Scarci M.
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):254-9. PubMed ID: 21044972
    [Abstract] [Full Text] [Related]

  • 4. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
    Sugarbaker DJ, Wolf AS, Chirieac LR, Godleski JJ, Tilleman TR, Jaklitsch MT, Bueno R, Richards WG.
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
    [Abstract] [Full Text] [Related]

  • 5. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
    Plathow C, Staab A, Schmaehl A, Aschoff P, Zuna I, Pfannenberg C, Peter SH, Eschmann S, Klopp M.
    Invest Radiol; 2008 Oct; 43(10):737-44. PubMed ID: 18791416
    [Abstract] [Full Text] [Related]

  • 6. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.
    Erasmus JJ, Truong MT, Smythe WR, Munden RF, Marom EM, Rice DC, Vaporciyan AA, Walsh GL, Sabloff BS, Broemeling LD, Stevens CW, Pisters KM, Podoloff DA, Macapinlac HA.
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1364-70. PubMed ID: 15942579
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose.
    Ceresoli GL, Chiti A, Zucali PA, Rodari M, Lutman RF, Salamina S, Incarbone M, Alloisio M, Santoro A.
    J Clin Oncol; 2006 Oct 01; 24(28):4587-93. PubMed ID: 17008700
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
    Lucchi M, Chella A, Melfi F, Dini P, Ambrogi M, Fino L, Fontanini G, Mussi A.
    Eur J Cardiothorac Surg; 2007 Mar 01; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
    [Abstract] [Full Text] [Related]

  • 14. [Extrapleural pneumonectomy of malignant pleural mesothelioma].
    Yoon HE, Nonaka K, Fukuhara K, Ueshima H, Sugiura T, Kaneda H, Shimamoto S, Imakita M, Iwase K.
    Kyobu Geka; 2004 Oct 01; 57(11):1011-5. PubMed ID: 15510813
    [Abstract] [Full Text] [Related]

  • 15. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S, Clementi M, Valenti M, Fiorentini G, Cantore M, Kanavos E, Amicucci G.
    In Vivo; 2006 Oct 01; 20(6A):715-8. PubMed ID: 17203752
    [Abstract] [Full Text] [Related]

  • 16. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
    Neragi-Miandoab S, Richards WG, Sugarbaker DJ.
    Int J Surg; 2008 Aug 01; 6(4):293-7. PubMed ID: 18585112
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
    Zahid I, Sharif S, Routledge T, Scarci M.
    Interact Cardiovasc Thorac Surg; 2011 May 01; 12(5):812-7. PubMed ID: 21345818
    [Abstract] [Full Text] [Related]

  • 19. [Long-term prognostic analysis of patients with malignant pleural mesothelioma].
    Cao KJ, Cui NJ.
    Ai Zheng; 2005 Jan 01; 24(1):72-5. PubMed ID: 15642204
    [Abstract] [Full Text] [Related]

  • 20. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy.
    Nakas A, Trousse DS, Martin-Ucar AE, Waller DA.
    Eur J Cardiothorac Surg; 2008 Oct 01; 34(4):886-91. PubMed ID: 18656373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.